Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Coagulation Factor VII Human

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Haemophilia

    02 3Haemophilia A

    03 1NovoSeven

    04 1of which Novoseven

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Haemophilia

    Recombinant Human Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Haemophilia

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Human Coagulation Factor VIIa

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 1,571

    2019 Revenue in Millions : 1,672

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Haemophilia A

    Recombinant Human Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Haemophilia A

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Human Coagulation Factor VIIa

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 322

    2020 Revenue in Millions : 274

    Growth (%) : 23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Haemophilia A

    Recombinant Human Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Haemophilia A

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Human Coagulation Factor VIIa

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 341

    2021 Revenue in Millions : 322

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : NovoSeven

    Recombinant Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : NovoSeven

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Coagulation Factor VIIa

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 1,157

    2022 Revenue in Millions : 1,212

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Haemophilia A

    Recombinant Human Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Haemophilia A

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Human Coagulation Factor VIIa

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 352

    2022 Revenue in Millions : 341

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Haemophilia

    Recombinant Human Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Haemophilia

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Human Coagulation Factor VIIa

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 1,436

    2017 Revenue in Millions : 1,570

    Growth (%) : -9%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : of which Novoseven

    Coagulation Factor VII [Recombinant]

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : of which Novoseven

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Coagulation Factor VII [Recombinant]

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 1,182

    2017 Revenue in Millions : 1,381

    Growth (%) : -14%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Haemophilia

    Recombinant Human Coagulation Factor VIIa

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Haemophilia

    Denmark
    arrow
    Antibody Engineering
    Not Confirmed

    Novo Nordisk

    Recombinant Human Coagulation Factor VIIa

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 1,542

    2018 Revenue in Millions : 1,436

    Growth (%) : 7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF